Douglas K. Graham, MD, PhD

P4537753

Titles and Roles

Director and Daniel P. Amos Children's Chair
Aflac Cancer and Blood Disorders Center
Professor, Department of Pediatrics
Emory University School of Medicine
Chief, Division of Pediatric Hematology/Oncology/BMT
Emory University School of Medicine
Pediatric Oncologist
Pediatric Cancer
Research Program
Discovery and Developmental Therapeutics

Biography

Douglas K. Graham, MD, PhD, is the director of the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta. Dr. Graham comes to the Aflac Cancer Center having previously served as professor of pediatrics and immunology at the University of Colorado, with clinical practice at Children's Hospital Colorado. While there, Dr. Graham led the Biology and Treatment of Childhood Cancer Research Emphasis Area for the hospital. He directly oversaw all basic science, translational and clinical oncology research for the hospital.

Dr. Graham is a National Institutes of Health-funded investigator with an active laboratory focusing on developing novel therapeutics for pediatric cancer, recently validating MerTK as a novel cancer agent in leukemia, melanoma, non-small cell lung cancer and glioblastoma. He was the co-program leader of the Hematologic Malignancy Program at the University of Colorado, a National Cancer Institute-designated cancer center.

Dr. Graham is a member of the Children's Oncology Group, COG Acute Myeloid Leukemia Disease Committee and the NIH Molecular and Cellular Hematology Study Section. He also holds memberships with American Society of Pediatric Hematology/Oncology, American Society of Hematology, American Society for Cancer Research, American Society for Clinical Investigation, Society for Pediatric Research and American Academy of Pediatrics.

Education

Dr. Graham received his Medical Degree as well as his PhD in Microbiology and Immunology from University of North Carolina in Chapel Hill, NC. He completed his residency in pediatrics and a fellowship in pediatric hematology/oncology at University of Colorado at Denver.

Research

Dr. Graham has an active research lab studying tyrosine kinase signaling pathways in cancer. In particular, his lab studies the Mer and Axl pathways in pediatric leukemia and pediatric brain cancer. They also study the role of these pathways in melanoma and non-small cell lung cancer. His laboratory is working to develop novel inhibitors of these pathways to hopefully move forward into clinical trials in the near future.

Publications

  • PublicationsPublication Date

Awards

Dr. Graham has received the following awards:

  • American Cancer Society Research Scholar Award, 2009-2012
  • Damon Runyon Cancer Research Foundation-Novartis Clinical Investigator Award, 2007-2012
  • Colorado Bioscience Discovery Award, 2007
  • Children's Oncology Group Young Investigator Award, 2006
  • New Inventor of the Year, University of Colorado Denver, 2006
Cascade Link   TOP